Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;38(12):7195-7201.
doi: 10.1007/s00464-024-11284-x. Epub 2024 Oct 4.

Predictors of postoperative bleeding after minimally invasive bariatric surgery

Raul Sebastian  1   2   3 , Alba Zevallos  4   5 , Jorge Cornejo  4 , Joaquin Sarmiento  4 , Christina Li  4 , Michael Schweitzer  6 , Gina L Adrales  6
Affiliations

Predictors of postoperative bleeding after minimally invasive bariatric surgery

Raul Sebastian et al. Surg Endosc. 2024 Dec.

Abstract

Background: Minimally invasive bariatric surgeries provide effective weight loss with fewer complications. However, postoperative bleeding remains a significant concern due to its potential for serious morbidity and mortality. This study aimed to identify factors predicting postoperative bleeding following laparoscopic and robotic sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB).

Methods: We analyzed patients who underwent SG and RYGB using the MBSAQIP database from 2015 to 2021. Four multivariate logistic regression analyses were conducted to investigate the relationship between postoperative bleeding and 24 independent factors for laparoscopic SG (lapSG), robotic SG (rSG), laparoscopic RYGB (lapRYGB), and robotic RYGB (rRYGB).

Results: We analyzed 659,294 lapSG, 53,548 rSG, 267,171 lapRYGB, and 22,492 rRYGB patients. In lapSG, the most significant factors included anticoagulation (OR 3.76; 95% CI 3.13-4.51), renal insufficiency (OR 2.06; 95% CI 1.37-3.09), history of DVT (OR 1.87; 95% CI 1.23-2.85), history of PE (OR 1.69; 95% CI 1.04-2.76, and BMI ≤ 40 (OR 1.22; 95% CI 1.09-1.38). In the rSG group, anticoagulation (OR 4.95; 95% CI 2.83-8.66), COPD (OR 2.80; 95% CI 1.29-6.05), and hyperlipidemia (OR 1.90; 95% CI 1.29-6.05) were significant factors. In lapRYGB, the most significant factors included anticoagulation (OR 3.68; 95% CI 3.11-4.35), renal insufficiency (OR 1.60; 95% CI 1.04-2.44), history of DVT (OR 1.70; 95% CI 1.09-2.07), cardiac stent (OR 1.51; 95% CI 1.09-2.07), and BMI ≤ 40 (OR 1.16; 95% CI 1.03-1.29). For rRYGB, anticoagulation (OR 4.69; 95% CI 2.86-7.70), history of PE (OR 4.28; 95% CI 1.53-12.00), and cardiac stent (OR 2.15; 95% CI 0.06-4.34) were significant.

Conclusion: Preoperative anticoagulation, renal insufficiency, history of DVT and PE, a cardiac stent, and BMI ≤ 40 are associated with an increased risk of postoperative bleeding. The predictive factors were consistent across laparoscopic and robotic approaches in SG and RYGB procedures.

Keywords: Bleeding; Gastric bypass; Minimally invasive surgery; Sleeve gastrectomy.

PubMed Disclaimer

Conflict of interest statement

Declarations. Disclosures: Alba Zevallos, Raul Sebastian, Jorge Cornejo, Joaquin Sarmiento, Christina Li, and Michael Schweitzer have no conflicts of interest or financial ties to disclose. Gina Adrales reports unrelated disclosures of honoraria for consulting for Caresyntax, Inc and Ethicon Johnson and Johnson Advisory Board.

References

    1. Clapp B, Wynn M, Martyn C, Foster C, O’Dell M, Tyroch A (2018) Long term (7 or more years) outcomes of the sleeve gastrectomy: a meta-analysis. Surg Obes Relat Dis 14:741–747. https://doi.org/10.1016/j.soard.2018.02.027 - DOI - PubMed
    1. American Society for Metabolic and Bariatric Surgery Estimate of Bariatric Surgery Numbers, 2011–2022. https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers/
    1. Biter LU, ‘t Hart JW, Noordman BJ, Smulders JF, Nienhuijs S, Dunkelgrün M, Zengerink JF, Birnie E, Friskes IA, Mannaerts GH, Apers JA (2024) Long-term effect of sleeve gastrectomy vs Roux-en-Y gastric bypass in people living with severe obesity: a phase III multicentre randomised controlled trial (SleeveBypass). Lancet Reg Health Eur. https://doi.org/10.1016/j.lanepe.2024.100836 - DOI - PubMed - PMC
    1. Alghamdi S, Mirghani H, Alhazmi K, Alatawi AM, Brnawi H, Alrasheed T, Badoghaish W (2022) Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy effects on obesity comorbidities: a systematic review and meta-analysis. Front Surg 9:953804. https://doi.org/10.3389/fsurg.2022.953804 - DOI - PubMed - PMC
    1. Mognol P, Chosidow D, Marmuse J-P (2006) Laparoscopic sleeve gastrectomy (LSG): review of a new bariatric procedure and initial results. Surg Technol Int 15:47–52 - PubMed

MeSH terms

LinkOut - more resources